N/A
N=362
Validation of the Stayhealthy BC1 Body Comp Analyzer
Body Composition
Bottom Line
View on ClinicalTrials.gov: NCT01209923 ↗Enrolled (actual)
362
Serious AEs
0.0%
Results posted
Jan 2022
Primary outcome: Primary: Percent Body Fat — 20.3; 20.4; 32.8; 33.4 percent body fat — p=0.001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- BC1 (Device)
- Age
- Pediatric, Adult, Older Adult · 10+ yrs
- Sex
- All
- Sponsor
- University of Southern California
- Primary completion
- Aug 2009
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percent Body Fat |
20.3; 20.4; 32.8; 33.4; 18.4; 18.8 | 0.001 sig |
Summary
The purpose of this study was to validate the Stayhealthy BC1 bioelectrical impedance analyzer to assess percent body fat in children and adults. The BC1 was compared to dual-energy x-ray absorptiometry assessment of body fat for adults and to hydrostatic weighing assessment of body fat for children. We hypothesized that the BC1 would provide similar measures of body fat between devices with acceptable limits of agreement.
Eligibility Criteria
Inclusion Criteria
- boys and girls 10-17 yrs and men and women 18-80 yrs
Exclusion Criteria
- acute illness
- pregnancy
- pacemaker or defibrillator
Data sourced from ClinicalTrials.gov (NCT01209923). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.